SIYOMICRO BIO-TECH Co., Ltd. is a cutting-edge biotech company with a focus on synthetic biology and intelligent manufacturing. Founded in 2016 in China, SIYOMICRO's mission is to customize the design and transformation of microbes in a green, clean, and sustainable way. The company aims to harness the most beneficial ingredients from nature to create active products through safe, environmental-friendly, and cost-saving methods within the Agriculture and Biotechnology sectors. SIYOMICRO's recent CNY200.00M Series B investment at 23 February 2022 has attracted significant attention. The investment was led by CICC, a renowned investment bank in China, along with participation from Aier Eye Hospital Group and Sinvo Group. This investment underscores the confidence these prominent investors have in SIYOMICRO's innovative approach to synthetic biology and intelligent manufacturing. SiyoMicro's slogan, "The World's Leading Synthetic Biology Innovate and Intelligent Manufacturing Enterpris," speaks to the company's pioneering spirit and commitment to driving the future of the industry. With a dedicated team of scientists and engineers, SIYOMICRO is well-positioned to play a key role in shaping the future of synthetic biology, benefiting both people and the planet. In summary, SIYOMICRO BIO-TECH Co., Ltd. is at the forefront of revolutionizing the biotech industry through its innovative and sustainable approach. The recent Series B investment and the backing of influential investors signify a promising trajectory for the company's growth and impact in the global biotech and agriculture sectors.
No recent news or press coverage available for SIYOMICRO BIO-TECH Co., Ltd..